What does Cannabis Strategic Ventures do?

Cannabis Strategic Ventures (NUGS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is NUGS's market cap?

Cannabis Strategic Ventures (NUGS) has a market capitalization of approximately $368,430, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does NUGS pay a dividend?

No — Cannabis Strategic Ventures (NUGS) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Cannabis Strategic Ventures (NUGS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

NUGS

Cannabis Strategic Ventures

OTC·Drug Manufacturers, Specialty & Generic · Healthcare

$0.00$0.00+0.00%

Market cap$368.43K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−98.21%CAGR −55.32%

Select date range

FromTo

Jul 16, 2015Aug 27, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

NUGS does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

Revenue$4.79M

Net Income−$9.87M

Net Margin−205.8%

Operating Cash Flow−$3.26M

Capital Expenditures$5.00

Free Cash Flow−$3.26M

Return on Equity—

Return on Invested Capital−36.1%

Net Debt$13.55M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for NUGS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how NUGS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for NUGS and 80,000+ other tickers.

About Cannabis Strategic Ventures

Cannabis Strategic Ventures specializes in cultivating cannabis products across the United States. Beyond its growing operations, the firm actively fosters new ventures, expands existing operations, and forms strategic alliances within the broader cannabis ecosystem and its supporting sectors. Its corporate headquarters are situated in Los Angeles, California.

CEO: Simon Yu
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: OTC
Employees: 30
Website: www.cannabisstrategic.com

Peers

Latest News

News Tab

No recent news available.

Frequently Asked Questions About NUGS

What does Cannabis Strategic Ventures do?: Cannabis Strategic Ventures (NUGS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is NUGS's market cap?: Cannabis Strategic Ventures (NUGS) has a market capitalization of approximately $368,430, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does NUGS pay a dividend?: No — Cannabis Strategic Ventures (NUGS) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is NUGS profitable?: Cannabis Strategic Ventures (NUGS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.